ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for NASDAQ stock FATE Fate Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 2.32 and Closed at: 2.43, which is 4.53% of previous session's close. It moved within a range of 2.29 and 2.58
The session was a Bullish session with an average volume of 3381400, which is 80.54% of previous session's volumes.

    A Dead cross was found 2 days back on short term averages

    A Golden cross was found 7 days back on short term averages

    Support for tomorrow is 2.36 and resistance for tomorrow is 2.65
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 2.29, 2.14 resistance for tomorrow's hourly charts is 2.58, 2.72

    10 Day SMA for Fate Therapeutics (FATE) is 2.39 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Fate Therapeutics (FATE) is 2.41 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Fate Therapeutics (FATE) is 2.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 2.43 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Fate Therapeutics is 1.87 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Fate Therapeutics is at 2.41 and 200 DMA is at 1.87, while 50 DMA and 100 DMA are at 2.48 and 2.43 respectively

    Fate Therapeutics (FATE) moving average of 20 SMA is at 2.41 and 20 EMA is at 2.4

    Fate Therapeutics (FATE) moving average of 50 SMA is at 2.48 and 50 EMA is at 2.44

    Fate Therapeutics (FATE) moving average of 100 SMA is at 2.43 and 100 EMA is at 2.3

    Fate Therapeutics (FATE) moving average of 200 SMA is at 1.87 and 200 EMA is at 2.02

    Xbiotech Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Xbiotech Inc, about 2.8% more returns!

    Fate Therapeutics has performed better than Voyager Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Solid Biosciences in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Surgery Partners in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Proqr Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Oncolytics Biotech in short term. Holding Fate Therapeutics could be a better choice for now!

    Lemaitre Vascular has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 4.56% more returns!

    Fate Therapeutics has performed better than Atyr Pharma in short term. Holding Fate Therapeutics could be a better choice for now!

    Intuitive Surgical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Intuitive Surgical, about 18.94% more returns!

    Immucell Corporation has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Immucell Corporation, about 1.89% more returns!

    Gossamer Bio has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Gossamer Bio, about 5819.47% more returns!

    Fate Therapeutics has performed better than Dariohealth Corp in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Corbus Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Caredx Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Caredx Inc, about 41.76% more returns!

    Beyondspring Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Beyondspring Inc, about 30.22% more returns!

    Fate Therapeutics has performed better than Biomarin Pharmaceutical in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics Technical analysis of indicators

    Price action analysis of Fate Therapeutics (FATE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

    ADX buy sell signal for Fate Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

    MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.

    MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

    Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

    Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Fate Therapeutics in short term and BUY signal is strong.

    RSI is generating a SELL signal in short term but selling is losing momentum.

    MRSI is in positive zone. This is a BUY zone

    Stock of Fate Therapeutics is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 2.4 and Fate Therapeutics FATE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

    People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

    Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And FATE Experts View which covers a lot of information including buying and selling signals

    FATE future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

    Chart Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

    Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

     

    Back to top